Efficacy and mechanistic study of dual specific inhibitor targeting Integrin αvβ3 and α5β1 against bone metastatic prostate cancer

Project Details

StatusActive
Effective start/end date31/03/2430/03/26

Funding

  • Royal Society: £12,000.00